Authors:
BRADY SF
STAUFFER KJ
LUMMA WC
SMITH GM
RAMJIT HG
LEWIS SD
LUCAS BJ
GARDELL SJ
LYLE EA
APPLEBY SD
COOK JJ
HOLAHAN MA
STRANIERI MT
LYNCH JJ
LIN JH
CHEN IW
VASTAG K
NAYLOROLSEN AM
VACCA JP
Citation: Sf. Brady et al., DISCOVERY AND DEVELOPMENT OF THE NOVEL POTENT ORALLY-ACTIVE THROMBIN INHIBITOR N-(9-HYDROXY-9-FLUORENECARBOXY)PROLYL TRANS-4-AMINOCYCLOHEXYLMETHYL AMIDE (L-372,460) - COAPPLICATION OF STRUCTURE-BASED DESIGN AND RAPID MULTIPLE ANALOG SYNTHESIS ON SOLID SUPPORT, Journal of medicinal chemistry, 41(3), 1998, pp. 401-406
Authors:
TUCKER TJ
LUMMA WC
LEWIS SD
GARDELL SJ
LUCAS BJ
SISKO JT
LYNCH JJ
LYLE EA
BASKIN EP
WOLTMANN RF
APPLEBY SD
Citation: Tj. Tucker et al., SYNTHESIS OF A SERIES OF POTENT AND ORALLY BIOAVAILABLE THROMBIN INHIBITORS THAT UTILIZE 3,3-DISUBSTITUTED PROPIONIC-ACID DERIVATIVES IN THE P-3 POSITION, Journal of medicinal chemistry, 40(22), 1997, pp. 3687-3693
Authors:
TUCKER TJ
LUMMA WC
LEWIS SD
GARDELL SJ
LUCAS BJ
BASKIN EP
WOLTMANN R
LYNCH JJ
LYLE EA
APPLEBY SD
CHEN IW
DANCHECK KB
VACCA JP
Citation: Tj. Tucker et al., POTENT NONCOVALENT THROMBIN INHIBITORS THAT UTILIZE THE UNIQUE AMINO-ACID D-DICYCLOHEXYLALANINE IN THE P3 POSITION - IMPLICATIONS ON ORAL BIOAVAILABILITY AND ANTITHROMBOTIC EFFICACY, Journal of medicinal chemistry, 40(11), 1997, pp. 1565-1569
Authors:
SHEN YT
WOLTMANN RF
APPLEBY SD
VOLKSDORF SR
PRAHALADA S
KRAUSE SM
KIVLIGHN SD
JOHNSON RG
SIEGL PK
LYNCH JJ
Citation: Yt. Shen et al., LACK OF BENEFICIAL-EFFECTS OF GROWTH-HORMONE TREATMENT IN CONSCIOUS DOGS DURING THE DEVELOPMENT OF CONGESTIVE-HEART-FAILURE, Circulation, 96(8), 1997, pp. 2768-2768
Authors:
LEWIS SD
NG AS
LYLE EA
MELLOTT MJ
APPLEBY SD
BRADY SF
STAUFFER KJ
SISKO JT
MAO SS
VEBER DF
NUTT RF
LYNCH JJ
COOK JJ
GARDELL SJ
SHAFER JA
Citation: Sd. Lewis et al., INHIBITION OF THROMBIN BY PEPTIDES CONTAINING LYSYL-ALPHA-KETO CARBONYL DERIVATIVES, Thrombosis and haemostasis, 74(4), 1995, pp. 1107-1112
Authors:
WALLACE AA
STUPIENSKI RF
BASKIN EP
APPLEBY SD
KOTHSTEIN T
GEHRET JR
KING SW
REMY DC
LYNCH JJ
Citation: Aa. Wallace et al., CARDIAC ELECTROPHYSIOLOGIC AND ANTIARRHYTHMIC ACTIONS OF TEDISAMIL, The Journal of pharmacology and experimental therapeutics, 273(1), 1995, pp. 168-175
Authors:
LYNCH JJ
WALLACE AA
STUPIENSKI RF
BASKIN EP
BEARE CM
APPLEBY SD
SALATA JJ
JURKIEWICZ NK
SANGUINETTI MC
STEIN RB
GEHRET JR
KOTHSTEIN T
CLAREMON DA
ELLIOTT JM
BUTCHER JW
REMY DC
BALDWIN JJ
Citation: Jj. Lynch et al., CARDIAC ELECTROPHYSIOLOGIC AND ANTIARRHYTHMIC ACTIONS OF 2 LONG-ACTING SPIROBENZOPYRAN PIPERIDINE CLASS-III AGENTS, L-702,958 AND L-706,000[MK-499], The Journal of pharmacology and experimental therapeutics, 269(2), 1994, pp. 541-554
Authors:
LYNCH JJ
WALLACE AA
VANDERGAAG LH
BASKIN EP
BEAR CM
GEHRET JR
KOTHSTEIN T
STUPIENSKI RF
APPLEBY SD
SANGUINETTI MC
JURKIEWICZ NK
ZINGARO GJ
STEIN RB
CLAREMON DA
ELLIOTT JM
YOUNG MB
BALDWIN JJ
Citation: Jj. Lynch et al., CARDIAC ELECTROPHYSIOLOGIC AND ANTIARRHYTHMIC ACTIONS OF 3,4-DIHYDRO-1'-[2-(BENZOFURAZAN-5-YL) AMIDOSPIRO[(2H)-1-BENZOPYRAN-2,4'-PIPERIDIN]-4-ONE HCL (L-691, 121), A NOVEL CLASS-III AGENT, The Journal of pharmacology and experimental therapeutics, 265(2), 1993, pp. 720-730